Research programme: cannabis based therapeutics - Canopy Growth/Entourage Phytolab

Drug Profile

Research programme: cannabis based therapeutics - Canopy Growth/Entourage Phytolab

Alternative Names: Cannabis-based therapeutics - Entourage Phytolab/Canopy Growth

Latest Information Update: 14 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Canopy Growth; Entourage Phytolab
  • Class Cannabinoids
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Unspecified

Most Recent Events

  • 28 Jun 2016 Canopy Growth and Entourage agree to co-develop cannabis based therapeutics in Brazil
  • 28 Jun 2016 Research in Undefined indication in Brazil before June 2016
  • 28 Jun 2016 Entourage announces intention to submit for market approval to ANVISA (Brazilian health surveillance agency) in 2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top